US Stock MarketDetailed Quotes
ZNTL Zentalis Pharmaceuticals
- 3.550
- +0.320+9.91%
Trading Nov 25 12:04 ET
252.99MMarket Cap-1420P/E (TTM)
3.600High3.280Low440.50KVolume3.330Open3.230Pre Close1.54MTurnover0.79%Turnover RatioLossP/E (Static)71.27MShares18.07052wk High0.71P/B197.40MFloat Cap2.66052wk Low--Dividend TTM55.61MShs Float87.190Historical High--Div YieldTTM9.91%Amplitude2.660Historical Low3.502Avg Price1Lot Size
Zentalis Pharmaceuticals Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Current assets | ||||||||||
| Cash, cash equivalents and short term investments | -24.27%391.25M | -93.31%36.98M | 24.58%488.98M | 10.41%482.92M | 10.41%482.92M | 22.51%516.64M | 21.48%552.99M | 35.65%392.52M | 28.68%437.37M | 28.68%437.37M |
| -Cash and cash equivalents | -62.69%41.32M | -86.13%36.98M | 3.68%37.62M | -34.90%28.04M | -34.90%28.04M | 160.28%110.75M | 383.39%266.56M | 18.67%36.28M | -27.87%43.07M | -27.87%43.07M |
| -Short-term investments | -13.79%349.93M | ---- | 26.70%451.37M | 15.36%454.88M | 15.36%454.88M | 7.04%405.89M | -28.41%286.43M | 37.65%356.24M | 40.74%394.3M | 40.74%394.3M |
| Receivables | ---- | ---- | ---- | ---- | ---- | --2.96M | -65.36%1.79M | ---- | ---- | ---- |
| -Accrued interest receivable | ---- | ---- | ---- | ---- | ---- | --1.93M | 88.82%878K | ---- | ---- | ---- |
| -Other receivables | ---- | ---- | ---- | ---- | ---- | --1.02M | -80.62%911K | ---- | ---- | ---- |
| Prepaid assets | ---- | ---- | ---- | ---- | ---- | --7.41M | 13.56%8.22M | ---- | ---- | ---- |
| Other current assets | 612.89%9.02M | 47,069.10%439.62M | -16.29%14.82M | -5.24%13.8M | -5.24%13.8M | -89.60%1.27M | --932K | --17.71M | 36.86%14.56M | 36.86%14.56M |
| Total current assets | -24.23%400.27M | -22.04%439.62M | 22.81%503.81M | 9.91%496.72M | 9.91%496.72M | 21.75%528.26M | 20.59%563.93M | 36.16%410.23M | 28.84%451.93M | 28.84%451.93M |
| Non current assets | ||||||||||
| Net PPE | -9.77%38.42M | ---- | -8.91%40.41M | -16.66%41.74M | -16.66%41.74M | -15.98%42.58M | -16.09%43.23M | -14.90%44.36M | -5.23%50.08M | -5.23%50.08M |
| -Gross PPE | -7.25%42.38M | ---- | -7.67%43.81M | -13.91%44.88M | -13.91%44.88M | -12.76%45.69M | -12.97%46M | -10.87%47.45M | -2.78%52.14M | -2.78%52.14M |
| -Accumulated depreciation | -27.15%-3.96M | ---- | -10.09%-3.41M | -52.82%-3.15M | -52.82%-3.15M | -82.95%-3.11M | -108.13%-2.76M | -178.40%-3.09M | -160.10%-2.06M | -160.10%-2.06M |
| Goodwill and other intangible assets | 0.00%3.74M | ---- | 0.00%3.74M | 0.00%3.74M | 0.00%3.74M | 0.00%3.74M | 0.00%3.74M | 0.00%3.74M | 0.00%3.74M | 0.00%3.74M |
| -Goodwill | 0.00%3.74M | 0.00%3.74M | 0.00%3.74M | 0.00%3.74M | 0.00%3.74M | 0.00%3.74M | 0.00%3.74M | 0.00%3.74M | 0.00%3.74M | 0.00%3.74M |
| Investments and advances | ---- | ---- | ---- | --0 | --0 | --0 | --0 | -47.12%18.9M | -43.42%21.21M | -43.42%21.21M |
| Other non current assets | -26.05%8.24M | 393.73%52.06M | -21.37%9.53M | -23.09%9.5M | -23.09%9.5M | -13.38%11.14M | -27.60%10.55M | -5.23%12.12M | 27.75%12.35M | 27.75%12.35M |
| Total non current assets | -12.29%50.39M | -9.48%52.06M | -32.16%53.67M | -37.09%54.97M | -37.09%54.97M | -39.72%57.45M | -42.62%57.52M | -24.21%79.12M | -15.77%87.38M | -15.77%87.38M |
| Total assets | -23.06%450.66M | -20.88%491.68M | 13.92%557.48M | 2.30%551.69M | 2.30%551.69M | 10.68%585.72M | 9.44%621.44M | 20.62%489.34M | 18.66%539.31M | 18.66%539.31M |
| Liabilities | ||||||||||
| Current liabilities | ||||||||||
| Payables | -42.50%8.2M | ---- | -18.07%10.5M | 32.71%14.93M | 32.71%14.93M | 40.28%14.26M | 1.51%12.93M | -7.52%12.82M | -2.96%11.25M | -2.96%11.25M |
| -accounts payable | -42.50%8.2M | 66.11%20.44M | -18.07%10.5M | 32.71%14.93M | 32.71%14.93M | 45.25%14.26M | 2.19%12.31M | -2.62%12.82M | -2.96%11.25M | -2.96%11.25M |
| -Total tax payable | ---- | ---- | ---- | ---- | ---- | ---- | -10.37%622K | ---- | ---- | ---- |
| Current accrued expenses | 4.53%46.68M | 26.73%46.25M | 1.74%44.3M | 19.91%54.44M | 19.91%54.44M | 7.12%44.65M | 6.82%36.5M | 53.55%43.54M | 40.32%45.4M | 40.32%45.4M |
| Current debt and capital lease obligation | ---- | ---- | ---- | ---- | ---- | ---- | 34.74%2.34M | ---- | ---- | ---- |
| -Current capital lease obligation | ---- | ---- | ---- | ---- | ---- | ---- | 34.74%2.34M | ---- | ---- | ---- |
| Current liabilities | -6.86%54.88M | 28.85%66.69M | -2.77%54.8M | 22.45%69.37M | 22.45%69.37M | 8.98%58.92M | 6.42%51.76M | 29.60%56.36M | 28.91%56.65M | 28.91%56.65M |
| Non current liabilities | ||||||||||
| Long term debt and capital lease obligation | -6.49%40.46M | -6.15%41.32M | -4.81%42.62M | -4.46%43.15M | -4.46%43.15M | --43.27M | -2.32%44.03M | -0.46%44.77M | 1.59%45.17M | 1.59%45.17M |
| -Long term capital lease obligation | -6.49%40.46M | -6.15%41.32M | -4.81%42.62M | -4.46%43.15M | -4.46%43.15M | --43.27M | -2.32%44.03M | -0.46%44.77M | 1.59%45.17M | 1.59%45.17M |
| Non current deferred liabilities | ---- | ---- | ---- | --0 | --0 | --0 | --0 | -51.16%756K | -47.41%853K | -47.41%853K |
| Non current accrued expenses | ---- | ---- | ---- | ---- | ---- | --1.63M | --2.38M | ---- | ---- | ---- |
| Other non current liabilities | --996K | ---- | -27.79%1.29M | -32.06%1.78M | -32.06%1.78M | ---- | ---- | --1.79M | --2.62M | --2.62M |
| Total non current liabilities | -7.68%41.45M | ---- | -7.20%43.91M | -7.63%44.93M | -7.63%44.93M | -3.22%44.9M | 0.01%46.4M | 1.70%47.32M | 5.55%48.64M | 5.55%48.64M |
| Total liabilities | -7.21%96.33M | 400.89%491.68M | -4.79%98.71M | 8.56%114.3M | 8.56%114.3M | 3.35%103.82M | 3.29%98.16M | 15.18%103.68M | 16.95%105.29M | 16.95%105.29M |
| Shareholders'equity | ||||||||||
| Share capital | 1.43%71K | --0 | 18.64%70K | 18.64%70K | 18.64%70K | 22.81%70K | 22.81%70K | 28.26%59K | 31.11%59K | 31.11%59K |
| -common stock | 1.43%71K | ---- | 18.64%70K | 18.64%70K | 18.64%70K | 22.81%70K | 22.81%70K | 28.26%59K | 31.11%59K | 31.11%59K |
| -Preferred stock | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Retained earnings | -21.66%-1.01B | -25.21%-966.77M | -33.19%-878.49M | -49.00%-888.56M | -49.00%-888.56M | -52.87%-827.64M | -58.55%-772.11M | -57.56%-659.58M | -65.86%-596.37M | -65.86%-596.37M |
| Paid-in capital | 3.81%1.36B | 4.14%1.35B | 27.82%1.34B | 28.32%1.32B | 28.32%1.32B | 34.73%1.31B | 34.78%1.3B | 42.25%1.05B | 42.55%1.03B | 42.55%1.03B |
| Gains losses not affecting retained earnings | 544.01%1.59M | ---- | 239.03%773K | 262.16%2.19M | 262.16%2.19M | 84.19%-359K | 81.00%-338K | 49.86%-556K | -982.40%-1.35M | -982.40%-1.35M |
| Other equity interest | ---- | --1.35B | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Total stockholders'equity | -26.45%354.33M | -26.87%382.58M | 19.01%458.77M | 0.80%437.28M | 0.80%437.28M | 12.43%481.77M | 10.72%523.14M | 22.26%385.49M | 19.19%433.8M | 19.19%433.8M |
| Noncontrolling interests | --0 | --0 | --0 | -51.58%107K | -51.58%107K | -44.87%129K | -57.66%141K | -51.63%178K | -58.14%221K | -58.14%221K |
| Total equity | -26.47%354.33M | ---- | 18.96%458.77M | 0.78%437.39M | 0.78%437.39M | 12.40%481.9M | 10.67%523.28M | 22.18%385.67M | 19.08%434.02M | 19.08%434.02M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data